造影剂注射器市场－全球产业规模、份额、趋势、机会和预测，按註射器类型、应用、最终用户、地区和竞争格局划分，2020-2030年预测

全球造影剂注射器市场规模在2024年为18.2亿美元，预计到2030年将以7.22%的复合年增长率增长至27.7亿美元。造影剂注射器是一种专用医疗器械，用于包括电脑断层扫描（CT）、磁振造影（MRI）和血管造影在内的诊断成像程序中，用于精确输送造影剂和生理盐水，从而提高图像清晰度和诊断准确性。市场成长的主要驱动因素是全球慢性病盛行率的上升以及由此带来的早期、精准诊断影像的需求，同时注射器系统的持续技术进步也提高了效率和病患安全性。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球造影剂注射器市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依注射器类型（单头、双头、无针注射器）
  • 依应用领域（放射线学、介入性心臟病学、其他）
  • 按最终使用者（医院和诊所、门诊中心、诊断中心）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美造影剂注射器市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲造影剂注射器市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区造影剂注射器市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲造影剂注射器市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲造影剂注射器市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球造影剂注射器市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Bracco Imaging SPA
• Bayer AG
• Guerbet Group
• Ulrich GmbH & Co. KG
• Nemoto Kyorindo Co., Ltd
• Sino Medical-Device Technology Inc.
• Apollo Retailing Co Ltd
• Shenzhen Anke High-tech Co. Ltd
• Shenzen Seacrown Electromechanical Co Ltd.
• Medtron Plc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Contrast Media Injectors Market-, valued at USD 1.82 Billion in 2024, is projected to experience a CAGR of 7.22% to reach USD 2.77 Billion by 2030. Contrast media injectors are specialized medical devices utilized in diagnostic imaging procedures, including computed tomography, magnetic resonance imaging, and angiography, to precisely deliver contrast agents and saline, thereby enhancing image clarity and diagnostic accuracy. The market's growth is primarily driven by the increasing global prevalence of chronic diseases and the subsequent demand for early and precise diagnostic imaging, alongside continuous technological advancements in injector systems that improve efficiency and patient safety.

Key Market Drivers

The escalating global prevalence of chronic diseases significantly contributes to the expansion of the contrast media injectors market. Conditions such as cardiovascular diseases, cancer, and neurological disorders necessitate frequent and accurate diagnostic imaging for early detection, staging, and monitoring of treatment efficacy. Contrast media injectors are indispensable in these procedures, including computed tomography angiography and magnetic resonance imaging, by enabling clear visualization of anatomical structures and pathological processes. The rising burden of these illnesses directly correlates with an increased volume of imaging tests requiring contrast enhancement, thereby driving demand for advanced injector systems. For instance, according to the American Cancer Society, in January 2024, an estimated 2,001,140 new cancer cases were projected to occur in the United States, underscoring a continuous need for diagnostic imaging reliant on contrast media.

Key Market Challenges

The substantial initial acquisition cost of advanced injector systems and their associated consumables represents a significant impediment to the growth of the Global Contrast Media Injectors Market. These high capital expenditures place considerable strain on healthcare budgets, particularly for institutions in developing regions with more constrained financial resources. This economic barrier directly limits the ability of many healthcare providers to invest in necessary upgrades or expand their diagnostic imaging capabilities, despite the proven clinical benefits of these advanced systems in enhancing image clarity and diagnostic accuracy.

Key Market Trends

The integration of artificial intelligence and machine learning in injectors represents a significant evolutionary shift in the Global Contrast Media Injectors Market. Beyond simply automating basic functions, AI and ML are increasingly enabling predictive analytics for patient-specific responses, real-time optimization of contrast flow rates, and seamless integration with broader hospital information systems for comprehensive patient management. This results in enhanced diagnostic accuracy, minimized contrast agent waste, and improved patient safety by reducing potential adverse reactions. According to the Radiological Society of North America (RSNA) 2024 meeting, artificial intelligence was a major focus, with over 200 exhibitors showcasing AI-related innovations. This signifies the widespread adoption and development within the medical imaging sector, of which contrast injectors are an integral part.

Key Market Players

• Bracco Imaging S.P.A
• Bayer A.G.
• Guerbet Group
• Ulrich GmbH & Co. KG
• Nemoto Kyorindo Co., Ltd
• Sino Medical-Device Technology Inc.
• Apollo Retailing Co Ltd
• Shenzhen Anke High-tech Co. Ltd
• Shenzen Seacrown Electromechanical Co Ltd.
• Medtron Plc.

Report Scope:

In this report, the Global Contrast Media Injectors Market- has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Contrast Media Injectors Market-, By Injector Type:

• Single-head
• Dual-head
• Syringeless

Contrast Media Injectors Market-, By Application:

• Radiology
• Interventional Cardiology
• Others

Contrast Media Injectors Market-, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Diagnostic Centers

Contrast Media Injectors Market-, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Contrast Media Injectors Market-.

Available Customizations:

Global Contrast Media Injectors Market- report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Contrast Media Injectors Market- Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Injector Type (Single-head, Dual-head, Syringeless)
  • 5.2.2. By Application (Radiology, Interventional Cardiology, Others)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Diagnostic Centers)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Contrast Media Injectors Market- Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Injector Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Contrast Media Injectors Market- Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Injector Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Contrast Media Injectors Market- Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Injector Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Contrast Media Injectors Market- Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Injector Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Contrast Media Injectors Market- Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Injector Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Contrast Media Injectors Market- Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Injector Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Contrast Media Injectors Market- Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Injector Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Contrast Media Injectors Market- Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Injector Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Contrast Media Injectors Market- Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Injector Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Contrast Media Injectors Market- Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Injector Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Contrast Media Injectors Market- Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Injector Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Contrast Media Injectors Market- Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Injector Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Contrast Media Injectors Market- Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Injector Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Contrast Media Injectors Market- Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Injector Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Contrast Media Injectors Market- Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Injector Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Contrast Media Injectors Market- Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Injector Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Contrast Media Injectors Market- Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Injector Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Contrast Media Injectors Market- Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Injector Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Contrast Media Injectors Market- Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Injector Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Contrast Media Injectors Market- Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Injector Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Contrast Media Injectors Market- Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Injector Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Contrast Media Injectors Market- Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Injector Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Contrast Media Injectors Market- Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Injector Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Contrast Media Injectors Market- Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Injector Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Contrast Media Injectors Market-: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Bracco Imaging S.P.A
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bayer A.G.
• 15.3. Guerbet Group
• 15.4. Ulrich GmbH & Co. KG
• 15.5. Nemoto Kyorindo Co., Ltd
• 15.6. Sino Medical-Device Technology Inc.
• 15.7. Apollo Retailing Co Ltd
• 15.8. Shenzhen Anke High-tech Co. Ltd
• 15.9. Shenzen Seacrown Electromechanical Co Ltd.
• 15.10. Medtron Plc.

16. Strategic Recommendations

17. About Us & Disclaimer